Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
54,403,891
-
Total 13F shares
-
17,488,772
-
Share change
-
+114,600
-
Total reported value
-
$146,733,000
-
Price per share
-
$8.39
-
Number of holders
-
40
-
Value change
-
+$663,192
-
Number of buys
-
13
-
Number of sells
-
22
Institutional Holders of Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) as of Q1 2022
As of 31 Mar 2022,
Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,488,772 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., SAMLYN CAPITAL, LLC, Woodline Partners LP, BlackRock Inc., VANGUARD GROUP INC, Monashee Investment Management LLC, GOLDMAN SACHS GROUP INC, Point72 Asset Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, and Hudson Bay Capital Management LP.
This page lists
40
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.